immagine

Attività svolta

Desidero ricevere una copia cartacea
Informativa sulla privacy
Iscrizione alla newsletter

Infezione da SARS-CoV-2 e ripercussioni cardiache nei carnivori domestici

Bibliografia 

1. Alifano M, Alifano P, Forgez P et coll. Renin-angiotensin system at the heart of COVID-19 pandemic. Biochimie. 2020;174:30-33.

2. Alsatli RA. Cardiovascular complications related to COVID-19 disease. Anesth. Essays Res. 2020;14(3):359-365.

3. Barroso-Arévalo S, Rivera B, Domínguez L et coll. First detection of SARS-CoV-2 B.1.1.7 variant of concern in an asymptomatic dog in Spain. Viruses. 2021;13(7):1379.

4. Barrs VR, Peiris M, Tam KWS et coll. SARS-CoV-2 in quarantined domestic cats from COVID-19 households or close contacts, Hong Kong, China. Emerg. Infect. Dis. 2020;26(12):3071-3074.

5. Bavishi C, Bonow RO, Trivedi V et coll. Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: a review. Prog. Cardiovasc. Dis. 2020;63(5):682-689.

6. Bearse M, Hung YP, Krauson AJ, et coll. Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19. Mod Pathol. 2021;34(7):1345-1357.

7. Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur. J. Clin. Microbiol Infect. Dis. 2021;40(5):905-919.

8. Bos JM, Hebl VB, Oberg AL et coll. Marked up-regulation of ACE2 in hearts of patients with obstructive hypertrophic cardiomyopathy: implications for SARS- CoV-2-mediated COVID-19. Mayo Clin. Proc. 2020;95(7):1354-1368.

9. Carvallo FR, Martins M, Joshi LR et coll. Severe SARS-CoV-2 infection in a cat with hypertrophic cardiomyopathy. Viruses. 2021;13(8):1510.

10. Chang WT, Toh HS, Liao CT et coll. Cardiac involvement of COVID-19: a comprehensive review. Am. J. Med. Sci. 2021;361(1):14-22.

11. ChappellMC, Marshall AC, Alzayadneh EM et coll. Update on the angiotensin converting enzyme 2-angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways. Front. Endocrinol. 2014;4:201.

12. Chen D, Li X, Song Q et coll. Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease 2019 inWenzhou, China. JAMA Netw. Open. 2020;3(6):e2011122.

13. Chetboul V, Foulex P, Kartout K et coll. Myocarditis and subclinical-like infection associated with SARS-CoV-2 in two cats living in the same household in France: a case report with literature review. Front. Vet. Sci. 2021;8:748869.

14. Devaux CA, Rolain JM, Raoult D. ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J. Microbiol. Immunol. Infect. 2020;53(3):425-435.

15. Driggin E, Madhavan MV, Bikdeli B et coll. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J. Am. Coll. Cardiol. 2020;75(18):2352-2371. 16. Ferasin L, Fritz M, Ferasin H et coll. Infection with SARS-CoV-2 variant B.1.1.7 detected in a group of dogs and cats with suspected myocarditis. Vet. Rec. 2021;189(9):e944.

17. Ferrario CM, Jessup J, ChappellMC et coll. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin- converting enzyme 2. Circulation. 24;111(20):2605-2610.

18. Garigliany M, Van Laere AS, Clercx C et coll. SARS-CoV-2 natural transmission from human to cat, Belgium, march 2020. Emerg. Infect. Dis. 2020;26(12):3069-3071.

19. Halfmann PJ, Hatta M, Chiba S et coll. Transmission of SARS-CoV-2 in domestic cats. N. Engl. J. Med. 2020;383(6):592-594.

20. Hamer SA, Ghai RR, Zecca IB et coll. SARS-CoV-2 B.1.1.7 variant of concern detected in a pet dog and cat after exposure to a person with COVID-19, USA. Transbound. Emerg. Dis. 2021:10.1111/tbed.14122.

21. Hamer SA, Pauvolid-Corrêa A, Zecca IB et coll. SARS-CoV-2 infections and viral isolations among serially tested cats and dogs in households with infected owners in Texas, USA. Viruses. 2021;13(5):938.

22. Hosie MJ, Epifano I, Herder V et coll. Detection of SARS-CoV-2 in respiratory samples from cats in the UK associated with human-to-cat transmission. Vet. Rec. 2021;188(8):e247.

23. Iacobellis G, Malavazos AE, Corsi MM. Epicardial fat: from the biomolecular aspects to the clinical practice. Int. J. Biochem. Cell Biol. 2011;43(12):1651-1654.

 24. Kariyanna PT, Sutarjono B, Grewal E et coll. A systematic review of COVID-19 and myocarditis. Am. J. Med. Case Rep. 2020;8(9):299-305.

25. Klaus J, Palizzotto C, Zini E et coll. SARS-CoV-2 infection and antibody response in a symptomatic cat from Italy with intestinal B-cell lymphoma. Viruses. 2021;13(3):527. 26. Kochi AN, Tagliari AP, Forleo GB et coll. Cardiac and arrhythmic complications in patients with COVID-19. J. Cardiovasc. Electrophysiol. 2020;31(5):1003-1008.

27. Lala A, Johnson KW, Januzzi JL et coll. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J. Am. Coll. Cardiol. 2020;76(5):533-546.

28. Limongelli G, Crotti L. COVID-19 pandemia and inherited cardiomyopathies and channelopathies: a short term and long-term perspective. Orphanet J. Rare Dis. 2020;15(1):157.

29. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19) : evidence from a meta-analysis. Prog. Cardiovasc. Dis. 2020;63(3):390-391.

30. Malavazos AE, Goldberger JJ, Iacobellis G. Does epicardial fat contribute to COVID-19 myocardial inflammation? Eur. Heart J. 2020;41(24):2333.

31. Michel JB. Système rénine-angiotensine et remodelage vasculaire. Med. Sci. (Paris). 2004;20(4):409-413.

32. Morris SB, Schwartz NG, Patel P et coll. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection - United Kingdom and United States, march-august 2020. MMWR Morb. Mortal. Wkly Rep. 2020;69(40):1450-1456.

33. Newman A, Smith D, Ghai RR et coll. First reported cases of SARS-CoV-2 infection in companion animals - New York, march-april 2020. MMWR Morb. Mortal. Wkly Rep. 2020;69(23):710-713.

34. Petrakis D, Margină D, Tsarouhas K et coll. Obesity: a risk factor for increased COVID-19 prevalence, severity and lethality (review). Mol. Med. Rep. 2020;22(1):9-19.

35. Sailleau C, Dumarest M, Vanhomwegen J et coll. First detection and genome sequencing of SARS-CoV-2 in an infected cat in France. Transbound. Emerg. Dis. 2020;67(6):2324-2328.

36. Sawalha K, Abozenah M, Kadado AJ et coll. Systematic review of COVID-19 related myocarditis: insights on management and outcome. Cardiovasc. Revasc. Med. 2021;23:107-113.

37. Segalés J, Puig M, Rodon J et coll. Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain. Proc. Natl. Acad. Sci. USA. 2020;117(40):24790-24793.

38. Shi J,Wen Z, Zhong G et coll. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020;368(6494):1016-1020.

39. Siripanthong B, Nazarian S, Muser D et coll. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463-1471.

40. Sit THC, Brackman CJ, Ip SM et coll. Infection of dogs with SARS-CoV-2. Nature. 2020;586(7831):776-778.

41. Valverde I, Singh Y, Sanchez-de-Toledo J et coll. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe. Circulation. 2021;143(1):21-32.

42. World Organisation for Animal Health (OIE). Questions and answers on COVID-19. 2021. https://www.oie.int/app/uploads/2021/03/a-covid-22-01-2021.pdf (accessed 22/02/2022).

43. Xu H, Zhong L, Deng J et coll. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 2020;12(1):8.

44. Zhu N, Zhang D,WangW et coll. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382(8):727-733.

TORNA INDIETRO
Abbonati per accedere

Dal web internazionale
02/02/2023

Patologia ed epidemiologia della vasculopatia glomerulare cutanea e renale

La vasculopatia glomerulare cutanea e renale (CRGV) è stata riconosciuta come una condizione che mette potenzialmente a rischio la vita dei cani nel Regno Unito dal 2012, sebbene vi sia stato un singolo caso (non azotemico) segnalato nel Regno Unito nel 2000.

 
 
Formazione a distanza abbinata a SUMMA

SPC-sviluppo-professionale-continuo